InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: Bunions post# 12049

Saturday, 11/07/2020 11:48:34 AM

Saturday, November 07, 2020 11:48:34 AM

Post# of 16706
This article from AGN shows NP120 with a lot of very high class competition. It is also interesting on what drugs were not included. End of 2020 readout for np120 is one of the first to results!

The NIH Video also talked about NDMA and cyclonite and actions to fight it. Rem is the SOC and new drugs need to be tested with it as a combo. Combinations of treatments and drugs are the future in the fight against COVID.
Vaccine talk was over my head but Trials and production for them will be important issues.
Minimal interactions and no long term safety issues were mentioned for Repurposed drugs' as past safety records will allow them to move to later Stage Trials and possible use quickly for specific indications.

Q? Are the sites where NP120 is being Trialed at using Rem as a SOC.?. One main concern brought up was will other drugs going to be conflicting with Rem which they are including as part of SOC?

US COVID cases raise to over 100K a day and world wide increases in infections are very concerning...GLTA...

PS...The NIH videocast will be reposted on their site soon so it can be watched again. It's 4 1/2 hrs long and I missed some. .